Similar to 18F-FDG PET/CT imaging, the fact that TSPO and FRβ are also expressed on various cancer cells to a variable degree may limit their usefulness as a targets for TAM imaging in tumors, although this may not be the case for all tumor types. This evidence concerns the gene TSPO and neoplasm.